Essential Partners’s Journey Medical DERM Stock Holding History

Essential Partners’s Portfolio DERM Stock Details DERM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-20	Closed	-$142	–	2897
2026 Q2	$142	Buy	+20	New	+$114	﹤0.01%	2699

Other funds holding DERM

Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return

Salem Investment Counselors Winston Salem, North Carolina $4.01B AUM 48.23% 1-Year Est. Return

Atria Investments Charlotte, North Carolina $10.3B AUM 19.62% 1-Year Est. Return

Essential Partners's DERM Position: Q3 2026 in Review

Essential Partners sold out of Journey Medical (DERM) in Q3 2026, closing a stake of 20 shares — an estimated $142 sold.

Essential Partners first reported a position in DERM in Q2 2026 and held it in 1 quarter. The position peaked at $142 in Q2 2026. 3 funds tracked by Wall St. Rank hold DERM as of Q3 2026.

Essential Partners reported no remaining Journey Medical position as of Q3 2026 after selling out during the quarter.
Essential Partners sold 20 Journey Medical shares in Q3 2026, an estimated $142.
Essential Partners first reported a position in Journey Medical in Q2 2026 and held it in 1 quarter.
Essential Partners's Journey Medical position peaked at $142 in Q2 2026.
3 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.